Nadali, G <br/><br/>
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.  [electronic resource] 

 -  Blood  Apr 1998 
 - 3011-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Biomarkers, Tumor<br/>Child<br/>Female<br/>Hodgkin Disease--blood<br/>Humans<br/>Ki-1 Antigen--blood<br/>Male<br/>Middle Aged<br/>Prognosis